SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-123122
Filing Date
2020-11-09
Accepted
2020-11-09 17:00:51
Documents
49
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q ntrp-20200930x10q.htm   iXBRL 10-Q 1419147
2 EXHIBIT 31.1 ntrp-20200930xex31d1.htm EX-31.1 10679
3 EXHIBIT 31.2 ntrp-20200930xex31d2.htm EX-31.2 10682
4 EXHIBIT 32.1 ntrp-20200930xex32d1.htm EX-32.1 5330
5 EXHIBIT 32.2 ntrp-20200930xex32d2.htm EX-32.2 5422
11 GRAPHIC ntrp-20200930x10q001.jpg GRAPHIC 7510
  Complete submission text file 0001104659-20-123122.txt   4779914

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ntrp-20200930.xsd EX-101.SCH 45430
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ntrp-20200930_cal.xml EX-101.CAL 24267
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ntrp-20200930_def.xml EX-101.DEF 168842
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ntrp-20200930_lab.xml EX-101.LAB 337995
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ntrp-20200930_pre.xml EX-101.PRE 291999
12 EXTRACTED XBRL INSTANCE DOCUMENT ntrp-20200930x10q_htm.xml XML 527588
Mailing Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS 3RD FLOOR NEW YORK NY 10036 (973) 242-0005
Neurotrope, Inc. (Filer) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38045 | Film No.: 201298583
SIC: 2834 Pharmaceutical Preparations